Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 4 of 4 entries
Sorted by: Best Match Show Resources per page
Involvement of Cannabinoid Signaling in Vincristine-Induced Gastrointestinal Dysmotility in the Rat.

Frontiers in pharmacology

Vera G, López-Pérez AE, Uranga JA, Girón R, Martín-Fontelles MI, Abalo R.
PMID: 28220074
Front Pharmacol. 2017 Feb 06;8:37. doi: 10.3389/fphar.2017.00037. eCollection 2017.

No abstract available.

Cite
Vera G, López-Pérez AE, Uranga JA, et al. Involvement of Cannabinoid Signaling in Vincristine-Induced Gastrointestinal Dysmotility in the Rat. Front Pharmacol. 2017;8:37doi: 10.3389/fphar.2017.00037.
Vera, G., López-Pérez, A. E., Uranga, J. A., Girón, R., Martín-Fontelles, M. I., & Abalo, R. (2017). Involvement of Cannabinoid Signaling in Vincristine-Induced Gastrointestinal Dysmotility in the Rat. Frontiers in pharmacology, 837. https://doi.org/10.3389/fphar.2017.00037
Vera, Gema, et al. "Involvement of Cannabinoid Signaling in Vincristine-Induced Gastrointestinal Dysmotility in the Rat." Frontiers in pharmacology vol. 8 (2017): 37. doi: https://doi.org/10.3389/fphar.2017.00037
Vera G, López-Pérez AE, Uranga JA, Girón R, Martín-Fontelles MI, Abalo R. Involvement of Cannabinoid Signaling in Vincristine-Induced Gastrointestinal Dysmotility in the Rat. Front Pharmacol. 2017 Feb 06;8:37. doi: 10.3389/fphar.2017.00037. eCollection 2017. PMID: 28220074; PMCID: PMC5292571.
Copy Download .nbib Format: NLM
[Cannabinoid and opioid system in the mechanisms and control of pain].

Reumatologia clinica

Goicoechea García C, Martín Fontelles MI.
PMID: 21794650
Reumatol Clin. 2009 Aug;5:5-8. doi: 10.1016/j.reuma.2009.04.006. Epub 2009 Jul 10.

Opium and Hashish have been classically employed for the control of pain. The pharmacologic rationale for the use of these substances lies in the fact that they are able to modulate the endogenous opioid and cannabinoid systems respectively. Both...

Cite
Goicoechea García C, Martín Fontelles MI. Sistemas cannabinoide y opioide en los mecanismos y el control del dolor. [Cannabinoid and opioid system in the mechanisms and control of pain]. Reumatol Clin. 2009;5:5-8doi: 10.1016/j.reuma.2009.04.006.
Goicoechea García, C., & Martín Fontelles, M. I. (2009). Sistemas cannabinoide y opioide en los mecanismos y el control del dolor. [Cannabinoid and opioid system in the mechanisms and control of pain]. Reumatologia clinica, 55-8. https://doi.org/10.1016/j.reuma.2009.04.006
Goicoechea García, Carlos, and Martín Fontelles, María Isabel. "Sistemas cannabinoide y opioide en los mecanismos y el control del dolor." [Cannabinoid and opioid system in the mechanisms and control of pain]. Reumatologia clinica vol. 5 (2009): 5-8. doi: https://doi.org/10.1016/j.reuma.2009.04.006
Goicoechea García C, Martín Fontelles MI. Sistemas cannabinoide y opioide en los mecanismos y el control del dolor. [Cannabinoid and opioid system in the mechanisms and control of pain]. Reumatol Clin. 2009 Aug;5:5-8. doi: 10.1016/j.reuma.2009.04.006. Epub 2009 Jul 10. Spanish. PMID: 21794650.
Copy Download .nbib Format: NLM
Efficacy of botulinum toxin type A in the management of masticatory myofascial pain: A retrospective clinical study.

Journal of the American Dental Association (1939)

de-la-Hoz JL, de-Pedro M, Martín-Fontelles I, Mesa-Jimenez J, Chivato T, Bagües A.
PMID: 34763815
J Am Dent Assoc. 2021 Nov 08; doi: 10.1016/j.adaj.2021.07.020. Epub 2021 Nov 08.

BACKGROUND: Muscular pain is the main cause of disability worldwide. Myofascial pain of orofacial origin is a frequent condition, the treatment of which is not always accomplished with traditional treatment. Botulinum toxin type A (BTA) is being studied for...

Cite
de-la-Hoz JL, de-Pedro M, Martín-Fontelles I, et al. Efficacy of botulinum toxin type A in the management of masticatory myofascial pain: A retrospective clinical study. J Am Dent Assoc. 2021;doi: 10.1016/j.adaj.2021.07.020.
de-la-Hoz, J. L., de-Pedro, M., Martín-Fontelles, I., Mesa-Jimenez, J., Chivato, T., & Bagües, A. (2021). Efficacy of botulinum toxin type A in the management of masticatory myofascial pain: A retrospective clinical study. Journal of the American Dental Association (1939), . https://doi.org/10.1016/j.adaj.2021.07.020
de-la-Hoz, Jose L, et al. "Efficacy of botulinum toxin type A in the management of masticatory myofascial pain: A retrospective clinical study." Journal of the American Dental Association (1939) vol. (2021). doi: https://doi.org/10.1016/j.adaj.2021.07.020
de-la-Hoz JL, de-Pedro M, Martín-Fontelles I, Mesa-Jimenez J, Chivato T, Bagües A. Efficacy of botulinum toxin type A in the management of masticatory myofascial pain: A retrospective clinical study. J Am Dent Assoc. 2021 Nov 08; doi: 10.1016/j.adaj.2021.07.020. Epub 2021 Nov 08. PMID: 34763815.
Copy Download .nbib Format: NLM
Fluoroscopic Characterization of Colonic Dysmotility Associated to Opioid and Cannabinoid Agonists in Conscious Rats.

Journal of neurogastroenterology and motility

Díaz-Ruano S, López-Pérez AE, Girón R, Pérez-García I, Martín-Fontelles MI, Abalo R.
PMID: 30870877
J Neurogastroenterol Motil. 2019 Apr 30;25(2):300-315. doi: 10.5056/jnm18202.

BACKGROUND/AIMS: Gastrointestinal adverse effects have a major impact on health and quality of life in analgesics users. Non-invasive methods to study gastrointestinal motility are of high interest. Fluoroscopy has been previously used to study gastrointestinal motility in small experimental...

Cite
Díaz-Ruano S, López-Pérez AE, Girón R, et al. Fluoroscopic Characterization of Colonic Dysmotility Associated to Opioid and Cannabinoid Agonists in Conscious Rats. J Neurogastroenterol Motil. 2019;25(2):300-315doi: 10.5056/jnm18202.
Díaz-Ruano, S., López-Pérez, A. E., Girón, R., Pérez-García, I., Martín-Fontelles, M. I., & Abalo, R. (2019). Fluoroscopic Characterization of Colonic Dysmotility Associated to Opioid and Cannabinoid Agonists in Conscious Rats. Journal of neurogastroenterology and motility, 25(2), 300-315. https://doi.org/10.5056/jnm18202
Díaz-Ruano, Susana, et al. "Fluoroscopic Characterization of Colonic Dysmotility Associated to Opioid and Cannabinoid Agonists in Conscious Rats." Journal of neurogastroenterology and motility vol. 25,2 (2019): 300-315. doi: https://doi.org/10.5056/jnm18202
Díaz-Ruano S, López-Pérez AE, Girón R, Pérez-García I, Martín-Fontelles MI, Abalo R. Fluoroscopic Characterization of Colonic Dysmotility Associated to Opioid and Cannabinoid Agonists in Conscious Rats. J Neurogastroenterol Motil. 2019 Apr 30;25(2):300-315. doi: 10.5056/jnm18202. PMID: 30870877; PMCID: PMC6474695.
Copy Download .nbib Format: NLM
Showing 1 to 4 of 4 entries